Larimar Therapeutics

Larimar Therapeutics Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR), a Pennsylvania-based clinical-stage biotechnology company specializing in treatments for complex rare diseases, announced this week that it has launched an underwritten …

Larimar Therapeutics Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants Read More